In gastric and pancreatic cancers, IGF2BP2 stabilizes oncogenic mRNAs and promotes glutamine metabolism, suggesting similar roles in the aggressive behavior seen in cancers like COAD and KIRP [110,111]. This evidence concerns the gene IGF2BP2 and cancer.